Home › Epstein-Barr Virus Infections › Texas
Epstein-Barr Virus Infections clinical trials in Texas
4 studies for Epstein-Barr Virus Infections are looking for participants at sites in Texas.
Cities in Texas
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- Baylor Scott and White Research Institute (Adults only), Dallas
- University of Texas Southwestern Medical Center - Children's Medical Center (Pediatrics only), Dallas
- MD Anderson Cancer Center (Pediatrics and Adult), Houston
RecruitingPhase 3
All ages · All sexes · Updated Sep 2, 2026 · NCT03394365A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The University of Texas, MD Anderson Cancer Center, Houston
- UT Health Mays Cancer Center, San Antonio
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 11, 2026 · NCT05592626EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma
- Harris Health System - Ben Taub General Hospital/Smith Clinic, Houston
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
- and 1 more
RecruitingPhase 1
All ages · All sexes · Updated Jun 25, 2026 · NCT04664179TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
RecruitingPhase 1
All ages · All sexes · Updated Jun 11, 2026 · NCT04013802From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.